Collaborating Authors


Bill Staikos on LinkedIn: #chatgpt


Well, I've got good news for you - ChatGPT is here to revolutionize the way we conduct user research. Recently, my team and I have been working on a new patient record interface for a big hospital in Israel (no pressure, right?), and we knew that creating use cases for different types of users was going to be a crucial step in the process. So, Instead of spending hours and hours writing them out by hand, we decided to put AI to the test! We did our brainstorming like usual, we identified the personas, their roles, jobs to be done, and only then we used ChatGPT to generate the use cases, and it was like having a wizard at our disposal! Chat responded with a variety of scenarios that we were able to use in the next brainstorming session.

The Lean Data Scientist

Communications of the ACM

Manning, C. Cross-lingual projected expectation regularization for weakly supervised learning.

Scientists gave a robot a sense of smell with locust antennae and AI


In 2023, there are cameras and microphones that match and surpass the capabilities of human sight and sound. But for all of our technological advancements, humans haven't quite managed to build a better nose. After all, evolution has had millions of years to perfect the receptors humans, animals and inspects use to identify odors. But, with the help of nature, scientists may have made a breakthrough on that front. In a study published Monday in the journal Biosensor and Bioelectronics, a group of researchers from Tel Aviv University (via Neuroscience News) said they recently created a robot that can identify a handful of smells with 10,000 times more sensitivity than some specialized electronics.

Where will artificial intelligence take us in the future? - The Jerusalem Post


The vast potential of Artificial Intelligence (AI) struck me during a trip to Guangzhou, China before the outbreak of COVID-19. I was asked, as editor of The Jerusalem Report, to address a news conference of Chinese journalists in English. To my surprise, I noticed that my speech was being relayed by an AI app in real time on a screen behind me – with subtitles in Chinese. The Oxford English Dictionary defines Artificial Intelligence, which was established as an academic discipline in 1956, as "the theory and development of computer systems able to perform tasks that normally require human intelligence, such as visual perception, speech recognition, decision-making, and translation between languages." "The theory and development of computer systems able to perform tasks that normally require human intelligence, such as visual perception, speech recognition, decision-making, and translation between languages."

Memristors Run AI Tasks at 1/800th Power - IEEE Spectrum


Memristive devices that mimic neuron-connecting synapses could serve as the hardware for neural networks that copy the way the brain learns. Now two new studies may help solve key problems these components face not just with yields and reliability, but with finding applications beyond neural nets. Memristors, or memory resistors, are essentially switches that can remember which electric state they were toggled to after their power is turned off. Scientists worldwide aim to use memristors and similar components to build electronics that, like neurons, can both compute and store data. These memristive devices may greatly reduce the energy and time lost in conventional microchips shuttling data back and forth between processors and memory.

Microscopy mash-up quantifies, maps neural circuits


By melding two microscopy methods and a computational tool, researchers can quickly and precisely quantify neuronal connections in individual animals, according to a new study. The technique could make it faster to map the connectomes of autism mouse models and track how mutations in autism-associated genes rewire neural circuits. A human neuron has thousands of synaptic connections, which light-based microscopy lacks the resolution to detect. Electron microscopy can resolve neuronal links in exquisite detail -- theoretically down to 0.12 nanometers, a length slightly shorter than a carbon-carbon chemical bond -- but the process is slow and laborious. In one study, it took about three years to section and image a single fly brain with a scanning electron microscope.

AI innovator Quris seed funding grows to $37 million - AI innovator Quris seed funding grows to $37 million


Quris, an artificial intelligence (AI) innovator in the pharmaceutical arena, has secured an additional $9 million in seed funding, expanding its total seed round funding to $37 million. Led by SoftBank Vision Fund 2, alongside existing private and institutional investors, such as GlenRock Capital, iAngels, Welltech Ventures, and Richter Group, the additional capital it to help Quris advance its Bio-AI platform, as well as broaden its team and industry collaborations and accelerate its novel drug research. Quris is the first Bio-AI clinical-prediction platform that simulates clinical trials by leveraging a patented patient-on-chip system, using stem-cell-derived tissue and AI to simulate a real human body's reaction to drugs, and thereby circumventing reliance on time-intense, inaccurate animal testing – timely, following a recent passage in the FDA Modernization Act to Ban Animal Testing Mandates. Quris' technology – developed in partnership with The New York Stem Cell Foundation (NYSCF) research institute – also aims to avoid the costly failure rate of drug candidates in clinical trials, which drive diminishing returns, cause consumer prices to soar, and negatively impact drug innovation. Yossi Cohen, director of Israel Operations for SoftBank Investment Advisers, said: "We believe the early forecasting capability that Quris is developing brings real potential impact to the global pharmaceutical industry."

$20 Million Funding For AI-Driven Microbiome-Based Therapeutics


Israeli startup Biomica today announced a $20 million financing round led by Shanghai Healthcare Capital (SHC). Biomica plans to use the new funding to further develop its pipeline of microbiome-based therapeutics. The human Microbiome, genetic material of all the microbes that live on and inside the human body. Biomica is a clinical-stage biopharmaceutical company developing therapies for antibiotic resistant bacteria, immuno-oncology, and microbiome-related gastrointestinal (GI) disorders. It is a subsidiary of Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), from which it licenses a dedicated Computational Predictive Biology platform (CPB).

The deep sea discoveries and sightings of 2022 are fascinating


An age of discovery is upon us. Big vessels, carrying robust robotic explorers and sometimes submersibles piloted by humans, embark on deep sea expeditions each year. This lightless realm remains a largely mysterious place, and just around 25 percent of the seafloor is decently mapped. Deep ocean missions are often considered the new exploration of little-known -- or just never-visited -- places on Earth. On the National Oceanic and Atmospheric Administration's (NOAA) six-month Voyage to the Ridge 2022, biologists spotted a curious, living "blue goo" on the Caribbean seafloor, at some 1,400 feet down.

Israeli AI Symptom Checker Performs Best, Says Study


A chatbot symptom checker developed in Israel performs better than seven rival products, according to an independent study. Symptom checkers use AI to simulate a conversation with a doctor, and provide a more accurate diagnosis than Googling a series of symptoms. However, physicians are skeptical to trust them, as they were designed to be used by patients rather than by doctors making diagnoses. A new study published in the International Journal of Medical Informatics (IJMI) found that Israeli-based Kahun gathered the best and most relevant insights. The researchers assessed the data-gathering capabilities of eight chatbot symptom checkers – K Health, Babylon, ADA, Buoy, Kahun, Mediktor, Symptomae, and Your.MD.